Drugs News and Research

RSS

The immunometabolic regulatory mechanisms for the pathogenesis of COVID-19

A new study aimed to analyze the immunometalobism BALF cells from mild to severe COVID-19 patients using computational algorithms that quantified metabolic fluxes and metabolic pathways.

13 Oct 2022

U.S. youth continue to be enticed and hooked by expanding variety of e-cigarettes, study shows

A study released today from the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention found that 2.55 million U.S. middle and high school students reported current (past 30-day) e-cigarette use in 2022, which includes 14.1% of high school students and 3.3% of middle school students.

12 Oct 2022

Study could help recommend the best treatment for women with early-stage mucinous ovarian cancer

A global study into mucinous ovarian cancer could help oncologists recommend the best treatment for women who are diagnosed early with the condition.

12 Oct 2022

Scientists show how cellular hypoxia response increases fetal hemoglobin expression in adults

Scientists at St. Jude Children's Research Hospital have shown how a protein responsible for adapting to low oxygen conditions (hypoxia), causes increased expression of fetal hemoglobin (HbF) in adults.

12 Oct 2022

Research shows how a very low dose of rhenium metal complex kills ovarian cancer cells

Metal-containing complexes have taken up center stage in the search for new cancer drugs that are as free of side effects as possible.

12 Oct 2022

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

A new study reported the real-world efficacy of oral antiviral therapies nirmatrelvir plus ritonavir, and molnupiravir on the SARS-CoV-2 Omicron (B.1.1.529) variant, based on an observational study among coronavirus disease 2019 (COVID-19) patients in Hong Kong.

12 Oct 2022

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

A recent study determines the relationship between molnupiravir and nirmatrelvir-ritonavir and all-cause mortality.

12 Oct 2022

BMI: The mismeasure of weight and the mistreatment of obesity

People who seek medical treatment for obesity or an eating disorder do so with the hope their health plan will pay for part of it. But whether it's covered often comes down to a measure invented almost 200 years ago by a Belgian mathematician as part of his quest to use statistics to define the "average man."

12 Oct 2022

Abortion bans are motivating midterm voters, poll shows

Half of voters say the Supreme Court's decision overturning the constitutional right to an abortion has made them more motivated to vote in next month's midterm elections, with enthusiasm growing especially among Democrats and those living in states with abortion bans, according to a new poll from KFF.

12 Oct 2022

Two new studies help improve the understanding of ovarian cancer

Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women's tumors do not respond to therapy.

11 Oct 2022

Common diabetes medication identified as a possible treatment for atrial fibrillation

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

11 Oct 2022

Cell-free DNA circulating in the blood may signal early signs of dementia and frailty

In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.

11 Oct 2022

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteins

In a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.

11 Oct 2022

Drugs News and Research

The immunometabolic regulatory mechanisms for the pathogenesis of COVID-19

U.S. youth continue to be enticed and hooked by expanding variety of e-cigarettes, study shows

Study could help recommend the best treatment for women with early-stage mucinous ovarian cancer

Scientists show how cellular hypoxia response increases fetal hemoglobin expression in adults

Research shows how a very low dose of rhenium metal complex kills ovarian cancer cells

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

BMI: The mismeasure of weight and the mistreatment of obesity

Abortion bans are motivating midterm voters, poll shows

Two new studies help improve the understanding of ovarian cancer

Common diabetes medication identified as a possible treatment for atrial fibrillation

Cell-free DNA circulating in the blood may signal early signs of dementia and frailty

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteins

Are men or women impacted more by adverse reactions to prescription drug treatments?

Hospitals have been slow to bring on addiction specialists

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

RNA-dependent RNA polymerase inhibitors in COVID-19 therapy

The role of wastewater surveillance for monitoring monkeypox

Zinc could improve the brain defects caused by rare genetic disorder

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News